BioCentury
ARTICLE | Finance

Choosy investors

Why 2018 will be a stock picker’s market in biotech

January 13, 2018 12:43 AM UTC

Despite losing steam in 4Q17, the broad-based recovery in biotech stocks last year has left investors generally comfortable with current valuations, and hence less optimistic that the sector indexes will outpace the broader market in 2018.

That doesn’t mean, however, that investors have turned bearish. Rather, the 17 buysiders who spoke with BioCentury about the coming year say prevailing headwinds should make it easier for stock pickers to outperform their benchmarks...